Harmony Biosciences Holdings - Stock Price History | HRMY

Historical daily share price chart and data for Harmony Biosciences Holdings since 2021 adjusted for splits. The latest closing stock price for Harmony Biosciences Holdings as of September 24, 2021 is 37.64.
  • The all-time high Harmony Biosciences Holdings stock closing price was 51.34 on November 10, 2020.
  • The Harmony Biosciences Holdings 52-week high stock price is 52.74, which is 40.1% above the current share price.
  • The Harmony Biosciences Holdings 52-week low stock price is 25.09, which is 33.3% below the current share price.
  • The average Harmony Biosciences Holdings stock price for the last 52 weeks is 34.36.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Harmony Biosciences Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 39.1184 37.0100 51.3400 30.9600 36.1500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.197B $0.160B
Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71